Metastatic lung cancer causing recurrent small-bowel intussusception
This lung cancer diagnosis at a glance
- Stage at diagnosis
- Stage IV
- Subtype
- Adenocarcinoma
- Biomarkers
- EGFR mutation; exon 19 deletion in metastatic bowel lesions
- Sex
- Female
- Spread to
- small bowel
- Treatment
- chemotherapy and surgery
- Outcome
- Living With Cancer
Treatment course, step by step
- Was receiving chemotherapy for active lung cancer before the bowel obstruction.
- Underwent laparotomy with reduction of jejunojejunal intussusception, resection of the involved small-bowel segment and formation of a double-barrel jejunostomy.
- Further cancer management was changed to palliation after metastatic bowel disease was confirmed.
What happened, in summary
A 55-year-old woman with active non-small cell lung cancer presented with 3 days of colicky abdominal pain, worsening nausea, vomiting and abdominal distension. She was already receiving chemotherapy. Her lung tumour carried an EGFR mutation, while an adrenal metastasis was only considered likely and is not treated as a confirmed metastatic site here.
CT showed duodenojejunal intussusception. Initial treatment with nasogastric drainage, fluids and total parenteral nutrition led to temporary improvement, but the obstruction repeatedly returned. On hospital day 14, she underwent laparotomy. Surgeons found a very proximal jejunojejunal intussusception, reduced it and resected the involved bowel segment, creating a double-barrel jejunostomy.
Pathology found multiple malignant polyps in the resected jejunum. The lesions were positive for markers supporting lung origin and showed both adenocarcinoma and high-grade neuroendocrine carcinoma. Genetic analysis identified an EGFR exon 19 deletion. The small-bowel lesions confirmed distant metastatic lung cancer, establishing Stage IV disease.
Her postoperative recovery was steady and satisfactory. After multidisciplinary review, further management shifted to palliation. Fluid and nutritional needs were optimized, stoma output was managed and long-term parenteral nutrition was planned.
Where this story comes from
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
Collections this story belongs to
- Stage 4 Lung Cancer 384 stories
- Stage 4 EGFR Mutation Lung Cancer 74 stories
- Chemotherapy for Stage 4 Lung Cancer 217 stories
- EGFR Mutation Lung Cancer 112 stories
- Chemotherapy for Lung Cancer 386 stories
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer